Onset of Action of Formoterol versus Salmeterol via Dry Powder Inhalers in Moderate Chronic Obstructive Pulmonary Disease: A Randomized, Placebo-Controlled, Double-Blind, Crossover Study.

Mario Cazzola,Pierluigi Paggiaro,Paolo Palange,Leif Bjermer,Pilar Ausin,Lars-Goran Carlsson,Jan Ekelund,Jan Lötvall

Onset of Action of Formoterol versus Salmeterol via Dry Powder Inhalers in Moderate Chronic Obstructive Pulmonary Disease: A Randomized, Placebo-Controlled, Double-Blind, Crossover Study.

2012

Mario Cazzola
Pierluigi Paggiaro
Paolo Palange
Leif Bjermer
Pilar Ausin
Lars-Goran Carlsson
Jan Ekelund
Jan Lötvall

Background: Bronchodilator therapy is central to the symptomatic management of chronic obstructive pulmonary disease (COPD), and treatment with short-acting bronchodilators is recommended in patients with mild COPD.

Keywords:

Anesthesia
Salmeterol
Medicine
Crossover study
Disease
Placebo
Bronchodilator
Formoterol
COPD
Onset of action
Pharmacotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations